Suppr超能文献

肝癌中的癌症干细胞和肝星状细胞。

Cancer Stem Cell and Hepatic Stellate Cells in Hepatocellular Carcinoma.

机构信息

Facultad de Medicina, Department of Biochemistry and Molecular Medicine, 27771Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.

出版信息

Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231163677. doi: 10.1177/15330338231163677.

Abstract

Hepatocellular carcinoma (HCC) is the most common liver cancer. It is highly lethal and has high recurrence. Death among HCC patients occur mainly due to tumor progression, recurrence, metastasis, and chemoresistance. Cancer stem cells (CSCs) are cell subpopulations within the tumor that promote invasion, recurrence, metastasis, and drug resistance. Hepatic stellate cells (HSCs) are important components of the tumor microenvironment (TME) responsible for primary secretory ECM proteins during liver injury and inflammation. These cells promote fibrogenesis, infiltrate the tumor stroma, and contribute to HCC development. Interactions between HSC and CSC and their microenvironment help promote carcinogenesis through different mechanisms. This review summarizes the roles of CSCs and HSCs in establishing the TME in primary liver tumors and describes their involvement in HCC chemoresistance.

摘要

肝细胞癌(HCC)是最常见的肝癌。它具有高度致命性和高复发率。 HCC 患者的死亡主要归因于肿瘤进展、复发、转移和化疗耐药。癌症干细胞(CSCs)是肿瘤内促进侵袭、复发、转移和耐药的细胞亚群。肝星状细胞(HSCs)是肿瘤微环境(TME)的重要组成部分,在肝损伤和炎症期间负责主要分泌 ECM 蛋白。这些细胞促进纤维化、浸润肿瘤基质,并有助于 HCC 的发展。HSC 和 CSC 及其微环境之间的相互作用通过不同的机制有助于促进癌变。本综述总结了 CSCs 和 HSCs 在原发性肝肿瘤中建立 TME 的作用,并描述了它们在 HCC 化疗耐药中的参与。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3b/10028642/4027857be0ca/10.1177_15330338231163677-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验